Aging studies present unique considerations due to their long duration and the significant amount of resources they require. JAX provides study-ready C57BL/6J males and females that are between 25-78 weeks of age. These mice are managed by JAX’s Genetic Stability Program and husbandry experts to minimize genetic drift. Visit the Aged C57BL/6J mouse page to learn more.
The following five references make recommendations that can improve their translational relevance, accuracy, and reproducibility.
Aging studies with mice should include all relevant stakeholders in planning and conducting the work:
An effective aging research program includes the collaboration and education of the research, husbandry, and veterinary staff, and of the members of the institution’s animal care and use committee. This collaborative effort is critical to humanely maintaining older mice and preventing excessive censorship due to non-lethal diseases. Part of the educational process is becoming familiar with how old mice appear clinically, at necropsy and histopathologically. This baseline knowledge is important in making the determination of humane end points, defining health span, contributing causes of death and effects of interventions.
Reproducibility has emerged as a significant concern, particularly for investigations using animal models. A failure to address the issue has the potential to erode public trust in science, waste valuable research resources, and further delay discoveries that could improve human health. Environmental factors such as diet, housing, and health status represent a highly significant potential source of phenotypic variation, especially for long term studies:
There needs to be increased awareness of these factors within the community but, as importantly, these parameters need to be captured and shared with publications. The ARRIVE guidelines cover all of the parameters identified here in detail and yet there is still a problem in persuading authors to provide this information and for journals to enforce their own policies. …
The bottom line, however, is that it is only with a firm commitment to disclosure and sharing by investigators, journals and funding agencies, and a recognition by the latter that, in many cases, ensuring reproducibility has a financial cost, that we will see better value for money from investment in model organism development and, in turn, a more robust translational pipeline.”
Improving reproducibility relies on thoroughly communicating the research methodologies—including the environmental factors—that may contribute to phenotypic variation. The Animal Research: Reporting of In Vivo Experiments ARRIVE Guidelines outline basic information needed about sample groups as well as key husbandry and housing parameters:
For pathology studies, however, investigators need to consult an important extension of the ARRIVE guidelines, the Recommendations for Minimum Information for Publication of Experimental Pathology data, or MINPEPA, which are guidelines that offer a checklist for design and reporting of reproducible pathology datasets, including morphological, immunohistochemical and/or in situ hybridization studies:
Schofield, P. N., J. M. Ward, and J. P. Sundberg. 2016. 'Show and tell: disclosure and data sharing in experimental pathology', Dis Model Mech, 9: 601-5. PMID: 27483498